Flatliners (2017)
.jpg)
| Theatrical Performance | ||
| Domestic Box Office | $16,883,115 | Details |
| International Box Office | $28,290,623 | |
| Worldwide Box Office | $45,173,738 | |
| Domestic Physical Disc Sales | ||
| DVD Sales (estimated) | $1,269,871 | |
| Blu-ray Sales (estimated) | $839,376 | |
| Total | $2,109,247 | |
| Further financial details... | ||
Synopsis
Five medical students, hoping to gain insight into the mystery of what lies beyond the confines of life, embark on a daring and dangerous experiment. By stopping their hearts for short periods of time, each triggers a near-death experience. As the investigation becomes more and more perilous, they are forced to confront the sins of their pasts, as well as contend with the paranormal consequences of trespassing to the other side.
Metrics
| Opening Weekend: | $6,574,326 (38.9% of total gross) |
| Legs: | 2.57 (domestic box office/biggest weekend) |
| Domestic Share: | 37.4% (domestic box office/worldwide) |
| Production Budget: | $20,000,000 (worldwide box office is 2.3 times production budget) |
| Theater counts: | 2,552 opening theaters/2,552 max. theaters, 3.2 weeks average run per theater |
| Infl. Adj. Dom. BO | $22,510,825 |
Movie Details
| Domestic Releases: | September 29th, 2017 (Wide) by Sony Pictures |
| International Releases: | September 27th, 2017 (Wide) (Trinidad)
September 27th, 2017 (Wide) (Jamaica) September 28th, 2017 (Wide) (Oman) September 28th, 2017 (Wide) (Bahrain) September 28th, 2017 (Wide) (Aruba) |
| Video Release: | December 12th, 2017 by Sony Pictures Home Entertainment |
| MPA Rating: | PG-13 for violence and terror, sexual content, language, thematic material, and some drug references. (Rating bulletin 2493 (Cert #50627), 9/13/2017) |
| Running Time: | 110 minutes |
| Franchise: | Flatliners |
| Cast, crew, or production detail: | Legacy Sequel, Reboot |
| Plot point: | Death of Other Extended Family, Human Experimentation, Medical Students, Near Death Experience |
| Social setting: | Supernatural |
| Subgenre: | Psychological Horror |
| Source: | Original Screenplay |
| Genre: | Horror |
| Production Method: | Live Action |
| Creative Type: | Science Fiction |
| Production/Financing Companies: | Columbia Pictures, Further Films, Laurence Mark, Cross Creek Pictures, The Safran Company |
| Production Countries: | United States |
| Languages: | English |
Weekend Box Office Performance
| Date | Rank | Gross | % Change | Theaters | Per Theater | Total Gross | Week |
|---|---|---|---|---|---|---|---|
| Sep 29, 2017 | 5 | $6,574,326 | 2,552 | $2,576 | $6,574,326 | 1 | |
| Oct 6, 2017 | 9 | $3,975,021 | -40% | 2,552 | $1,558 | $12,504,623 | 2 |
| Oct 13, 2017 | 12 | $1,544,995 | -61% | 1,983 | $779 | $15,672,966 | 3 |
| Oct 20, 2017 | 21 | $288,022 | -81% | 535 | $538 | $16,483,073 | 4 |
| Oct 27, 2017 | 31 | $129,605 | -55% | 263 | $493 | $16,715,404 | 5 |
| Nov 3, 2017 | 41 | $50,924 | -61% | 104 | $490 | $16,815,632 | 6 |
| Nov 10, 2017 | 50 | $25,015 | -51% | 67 | $373 | $16,857,840 | 7 |
| Nov 17, 2017 | 54 | $11,027 | -56% | 33 | $334 | $16,877,430 | 8 |
Daily Box Office Performance
| Date | Rank | Gross | %YD | %LW | Theaters | Per Theater | Total Gross | Days |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2017 | 5 | $2,128,957 | 2,552 | $834 | $2,128,957 | 1 | ||
| Sep 30, 2017 | 5 | $2,830,333 | +33% | 2,552 | $1,109 | $4,959,290 | 2 | |
| Oct 1, 2017 | 5 | $1,615,036 | -43% | 2,552 | $633 | $6,574,326 | 3 | |
| Oct 2, 2017 | 4 | $440,941 | -73% | 2,552 | $173 | $7,015,267 | 4 | |
| Oct 3, 2017 | 4 | $696,914 | +58% | 2,552 | $273 | $7,712,181 | 5 | |
| Oct 4, 2017 | 5 | $404,752 | -42% | 2,552 | $159 | $8,116,933 | 6 | |
| Oct 5, 2017 | 5 | $412,669 | +2% | 2,552 | $162 | $8,529,602 | 7 | |
| Oct 6, 2017 | 9 | $1,087,822 | +164% | -49% | 2,552 | $426 | $9,617,424 | 8 |
| Oct 7, 2017 | 8 | $1,658,666 | +52% | -41% | 2,552 | $650 | $11,276,090 | 9 |
| Oct 8, 2017 | 9 | $1,228,533 | -26% | -24% | 2,552 | $481 | $12,504,623 | 10 |
| Oct 9, 2017 | 9 | $616,792 | -50% | +40% | 2,552 | $242 | $13,121,415 | 11 |
| Oct 10, 2017 | 9 | $470,373 | -24% | -33% | 2,552 | $184 | $13,591,788 | 12 |
| Oct 11, 2017 | 9 | $319,390 | -32% | -21% | 2,552 | $125 | $13,911,178 | 13 |
| Oct 12, 2017 | 9 | $216,793 | -32% | -47% | 2,552 | $85 | $14,127,971 | 14 |
| Oct 13, 2017 | 12 | $475,592 | +119% | -56% | 1,983 | $240 | $14,603,563 | 15 |
| Oct 14, 2017 | 12 | $680,784 | +43% | -59% | 1,983 | $343 | $15,284,347 | 16 |
| Oct 15, 2017 | 12 | $388,619 | -43% | -68% | 1,983 | $196 | $15,672,966 | 17 |
| Oct 16, 2017 | 12 | $134,404 | -65% | -78% | 1,983 | $68 | $15,807,370 | 18 |
| Oct 17, 2017 | 12 | $172,989 | +29% | -63% | 1,983 | $87 | $15,980,359 | 19 |
| Oct 18, 2017 | 12 | $126,149 | -27% | -61% | 1,983 | $64 | $16,106,508 | 20 |
| Oct 19, 2017 | 13 | $88,543 | -30% | -59% | 1,983 | $45 | $16,195,051 | 21 |
| Oct 20, 2017 | - | $84,393 | -5% | -82% | 535 | $158 | $16,279,444 | 22 |
| Oct 21, 2017 | - | $123,069 | +46% | -82% | 535 | $230 | $16,402,513 | 23 |
| Oct 22, 2017 | - | $80,560 | -35% | -79% | 535 | $151 | $16,483,073 | 24 |
| Oct 23, 2017 | - | $29,724 | -63% | -78% | 535 | $56 | $16,512,797 | 25 |
| Oct 24, 2017 | - | $32,341 | +9% | -81% | 535 | $60 | $16,545,138 | 26 |
| Oct 25, 2017 | - | $22,597 | -30% | -82% | 535 | $42 | $16,567,735 | 27 |
| Oct 26, 2017 | - | $18,064 | -20% | -80% | 535 | $34 | $16,585,799 | 28 |
| Oct 27, 2017 | - | $33,785 | +87% | -60% | 263 | $128 | $16,619,584 | 29 |
| Oct 28, 2017 | - | $56,525 | +67% | -54% | 263 | $215 | $16,676,109 | 30 |
| Oct 29, 2017 | - | $39,295 | -30% | -51% | 263 | $149 | $16,715,404 | 31 |
| Oct 30, 2017 | - | $13,550 | -66% | -54% | 263 | $52 | $16,728,954 | 32 |
| Oct 31, 2017 | - | $14,961 | +10% | -54% | 263 | $57 | $16,743,915 | 33 |
| Nov 1, 2017 | - | $11,139 | -26% | -51% | 263 | $42 | $16,755,054 | 34 |
| Nov 2, 2017 | - | $9,654 | -13% | -47% | 263 | $37 | $16,764,708 | 35 |
| Nov 3, 2017 | - | $13,618 | +41% | -60% | 104 | $131 | $16,778,326 | 36 |
| Nov 4, 2017 | - | $22,934 | +68% | -59% | 104 | $221 | $16,801,260 | 37 |
| Nov 5, 2017 | - | $14,372 | -37% | -63% | 104 | $138 | $16,815,632 | 38 |
| Nov 6, 2017 | - | $4,051 | -72% | -70% | 104 | $39 | $16,819,683 | 39 |
| Nov 7, 2017 | - | $4,593 | +13% | -69% | 104 | $44 | $16,824,276 | 40 |
| Nov 8, 2017 | - | $4,202 | -9% | -62% | 104 | $40 | $16,828,478 | 41 |
| Nov 9, 2017 | - | $4,347 | +3% | -55% | 104 | $42 | $16,832,825 | 42 |
| Nov 10, 2017 | - | $7,077 | +63% | -48% | 67 | $106 | $16,839,902 | 43 |
| Nov 11, 2017 | - | $11,281 | +59% | -51% | 67 | $168 | $16,851,183 | 44 |
| Nov 12, 2017 | - | $6,657 | -41% | -54% | 67 | $99 | $16,857,840 | 45 |
| Nov 13, 2017 | - | $2,219 | -67% | -45% | 67 | $33 | $16,860,059 | 46 |
| Nov 14, 2017 | - | $2,441 | +10% | -47% | 67 | $36 | $16,862,500 | 47 |
| Nov 15, 2017 | - | $1,934 | -21% | -54% | 67 | $29 | $16,864,434 | 48 |
| Nov 16, 2017 | - | $1,969 | +2% | -55% | 67 | $29 | $16,866,403 | 49 |
| Nov 17, 2017 | - | $2,773 | +41% | -61% | 33 | $84 | $16,869,176 | 50 |
| Nov 18, 2017 | - | $4,881 | +76% | -57% | 33 | $148 | $16,874,057 | 51 |
| Nov 19, 2017 | - | $3,373 | -31% | -49% | 33 | $102 | $16,877,430 | 52 |
Weekly Box Office Performance
| Date | Rank | Gross | % Change | Theaters | Per Theater | Total Gross | Week |
|---|---|---|---|---|---|---|---|
| Sep 29, 2017 | 5 | $8,529,602 | 2,552 | $3,342 | $8,529,602 | 1 | |
| Oct 6, 2017 | 9 | $5,598,369 | -34% | 2,552 | $2,194 | $14,127,971 | 2 |
| Oct 13, 2017 | 12 | $2,067,080 | -63% | 1,983 | $1,042 | $16,195,051 | 3 |
| Oct 20, 2017 | 21 | $390,748 | -81% | 535 | $730 | $16,585,799 | 4 |
| Oct 27, 2017 | 32 | $178,909 | -54% | 263 | $680 | $16,764,708 | 5 |
| Nov 3, 2017 | 44 | $68,117 | -62% | 104 | $655 | $16,832,825 | 6 |
| Nov 10, 2017 | 50 | $33,578 | -51% | 67 | $501 | $16,866,403 | 7 |
Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services. For more information, please contact us at research@the-numbers.com.
Synopsis
Five medical students, hoping to gain insight into the mystery of what lies beyond the confines of life, embark on a daring and dangerous experiment. By stopping their hearts for short periods of time, each triggers a near-death experience. As the investigation becomes more and more perilous, they are forced to confront the sins of their pasts, as well as contend with the paranormal consequences of trespassing to the other side.
Metrics
| Opening Weekend: | $6,574,326 (38.9% of total gross) |
| Legs: | 2.57 (domestic box office/biggest weekend) |
| Domestic Share: | 37.4% (domestic box office/worldwide) |
| Production Budget: | $20,000,000 (worldwide box office is 2.3 times production budget) |
| Theater counts: | 2,552 opening theaters/2,552 max. theaters, 3.2 weeks average run per theater |
| Infl. Adj. Dom. BO | $22,510,825 |
Movie Details
| Domestic Releases: | September 29th, 2017 (Wide) by Sony Pictures |
| International Releases: | September 27th, 2017 (Wide) (Trinidad)
September 27th, 2017 (Wide) (Jamaica) September 28th, 2017 (Wide) (Oman) September 28th, 2017 (Wide) (Bahrain) September 28th, 2017 (Wide) (Aruba) |
| Video Release: | December 12th, 2017 by Sony Pictures Home Entertainment |
| MPA Rating: | PG-13 for violence and terror, sexual content, language, thematic material, and some drug references. (Rating bulletin 2493 (Cert #50627), 9/13/2017) |
| Running Time: | 110 minutes |
| Franchise: | Flatliners |
| Cast, crew, or production detail: | Legacy Sequel, Reboot |
| Plot point: | Death of Other Extended Family, Human Experimentation, Medical Students, Near Death Experience |
| Social setting: | Supernatural |
| Subgenre: | Psychological Horror |
| Source: | Original Screenplay |
| Genre: | Horror |
| Production Method: | Live Action |
| Creative Type: | Science Fiction |
| Production/Financing Companies: | Columbia Pictures, Further Films, Laurence Mark, Cross Creek Pictures, The Safran Company |
| Production Countries: | United States |
| Languages: | English |
Weekend Box Office Performance
| Date | Rank | Gross | % Change | Theaters | Per Theater | Total Gross | Week |
|---|---|---|---|---|---|---|---|
| Sep 29, 2017 | 5 | $6,574,326 | 2,552 | $2,576 | $6,574,326 | 1 | |
| Oct 6, 2017 | 9 | $3,975,021 | -40% | 2,552 | $1,558 | $12,504,623 | 2 |
| Oct 13, 2017 | 12 | $1,544,995 | -61% | 1,983 | $779 | $15,672,966 | 3 |
| Oct 20, 2017 | 21 | $288,022 | -81% | 535 | $538 | $16,483,073 | 4 |
| Oct 27, 2017 | 31 | $129,605 | -55% | 263 | $493 | $16,715,404 | 5 |
| Nov 3, 2017 | 41 | $50,924 | -61% | 104 | $490 | $16,815,632 | 6 |
| Nov 10, 2017 | 50 | $25,015 | -51% | 67 | $373 | $16,857,840 | 7 |
| Nov 17, 2017 | 54 | $11,027 | -56% | 33 | $334 | $16,877,430 | 8 |
Daily Box Office Performance
| Date | Rank | Gross | %YD | %LW | Theaters | Per Theater | Total Gross | Days |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2017 | 5 | $2,128,957 | 2,552 | $834 | $2,128,957 | 1 | ||
| Sep 30, 2017 | 5 | $2,830,333 | +33% | 2,552 | $1,109 | $4,959,290 | 2 | |
| Oct 1, 2017 | 5 | $1,615,036 | -43% | 2,552 | $633 | $6,574,326 | 3 | |
| Oct 2, 2017 | 4 | $440,941 | -73% | 2,552 | $173 | $7,015,267 | 4 | |
| Oct 3, 2017 | 4 | $696,914 | +58% | 2,552 | $273 | $7,712,181 | 5 | |
| Oct 4, 2017 | 5 | $404,752 | -42% | 2,552 | $159 | $8,116,933 | 6 | |
| Oct 5, 2017 | 5 | $412,669 | +2% | 2,552 | $162 | $8,529,602 | 7 | |
| Oct 6, 2017 | 9 | $1,087,822 | +164% | -49% | 2,552 | $426 | $9,617,424 | 8 |
| Oct 7, 2017 | 8 | $1,658,666 | +52% | -41% | 2,552 | $650 | $11,276,090 | 9 |
| Oct 8, 2017 | 9 | $1,228,533 | -26% | -24% | 2,552 | $481 | $12,504,623 | 10 |
| Oct 9, 2017 | 9 | $616,792 | -50% | +40% | 2,552 | $242 | $13,121,415 | 11 |
| Oct 10, 2017 | 9 | $470,373 | -24% | -33% | 2,552 | $184 | $13,591,788 | 12 |
| Oct 11, 2017 | 9 | $319,390 | -32% | -21% | 2,552 | $125 | $13,911,178 | 13 |
| Oct 12, 2017 | 9 | $216,793 | -32% | -47% | 2,552 | $85 | $14,127,971 | 14 |
| Oct 13, 2017 | 12 | $475,592 | +119% | -56% | 1,983 | $240 | $14,603,563 | 15 |
| Oct 14, 2017 | 12 | $680,784 | +43% | -59% | 1,983 | $343 | $15,284,347 | 16 |
| Oct 15, 2017 | 12 | $388,619 | -43% | -68% | 1,983 | $196 | $15,672,966 | 17 |
| Oct 16, 2017 | 12 | $134,404 | -65% | -78% | 1,983 | $68 | $15,807,370 | 18 |
| Oct 17, 2017 | 12 | $172,989 | +29% | -63% | 1,983 | $87 | $15,980,359 | 19 |
| Oct 18, 2017 | 12 | $126,149 | -27% | -61% | 1,983 | $64 | $16,106,508 | 20 |
| Oct 19, 2017 | 13 | $88,543 | -30% | -59% | 1,983 | $45 | $16,195,051 | 21 |
| Oct 20, 2017 | - | $84,393 | -5% | -82% | 535 | $158 | $16,279,444 | 22 |
| Oct 21, 2017 | - | $123,069 | +46% | -82% | 535 | $230 | $16,402,513 | 23 |
| Oct 22, 2017 | - | $80,560 | -35% | -79% | 535 | $151 | $16,483,073 | 24 |
| Oct 23, 2017 | - | $29,724 | -63% | -78% | 535 | $56 | $16,512,797 | 25 |
| Oct 24, 2017 | - | $32,341 | +9% | -81% | 535 | $60 | $16,545,138 | 26 |
| Oct 25, 2017 | - | $22,597 | -30% | -82% | 535 | $42 | $16,567,735 | 27 |
| Oct 26, 2017 | - | $18,064 | -20% | -80% | 535 | $34 | $16,585,799 | 28 |
| Oct 27, 2017 | - | $33,785 | +87% | -60% | 263 | $128 | $16,619,584 | 29 |
| Oct 28, 2017 | - | $56,525 | +67% | -54% | 263 | $215 | $16,676,109 | 30 |
| Oct 29, 2017 | - | $39,295 | -30% | -51% | 263 | $149 | $16,715,404 | 31 |
| Oct 30, 2017 | - | $13,550 | -66% | -54% | 263 | $52 | $16,728,954 | 32 |
| Oct 31, 2017 | - | $14,961 | +10% | -54% | 263 | $57 | $16,743,915 | 33 |
| Nov 1, 2017 | - | $11,139 | -26% | -51% | 263 | $42 | $16,755,054 | 34 |
| Nov 2, 2017 | - | $9,654 | -13% | -47% | 263 | $37 | $16,764,708 | 35 |
| Nov 3, 2017 | - | $13,618 | +41% | -60% | 104 | $131 | $16,778,326 | 36 |
| Nov 4, 2017 | - | $22,934 | +68% | -59% | 104 | $221 | $16,801,260 | 37 |
| Nov 5, 2017 | - | $14,372 | -37% | -63% | 104 | $138 | $16,815,632 | 38 |
| Nov 6, 2017 | - | $4,051 | -72% | -70% | 104 | $39 | $16,819,683 | 39 |
| Nov 7, 2017 | - | $4,593 | +13% | -69% | 104 | $44 | $16,824,276 | 40 |
| Nov 8, 2017 | - | $4,202 | -9% | -62% | 104 | $40 | $16,828,478 | 41 |
| Nov 9, 2017 | - | $4,347 | +3% | -55% | 104 | $42 | $16,832,825 | 42 |
| Nov 10, 2017 | - | $7,077 | +63% | -48% | 67 | $106 | $16,839,902 | 43 |
| Nov 11, 2017 | - | $11,281 | +59% | -51% | 67 | $168 | $16,851,183 | 44 |
| Nov 12, 2017 | - | $6,657 | -41% | -54% | 67 | $99 | $16,857,840 | 45 |
| Nov 13, 2017 | - | $2,219 | -67% | -45% | 67 | $33 | $16,860,059 | 46 |
| Nov 14, 2017 | - | $2,441 | +10% | -47% | 67 | $36 | $16,862,500 | 47 |
| Nov 15, 2017 | - | $1,934 | -21% | -54% | 67 | $29 | $16,864,434 | 48 |
| Nov 16, 2017 | - | $1,969 | +2% | -55% | 67 | $29 | $16,866,403 | 49 |
| Nov 17, 2017 | - | $2,773 | +41% | -61% | 33 | $84 | $16,869,176 | 50 |
| Nov 18, 2017 | - | $4,881 | +76% | -57% | 33 | $148 | $16,874,057 | 51 |
| Nov 19, 2017 | - | $3,373 | -31% | -49% | 33 | $102 | $16,877,430 | 52 |
Weekly Box Office Performance
| Date | Rank | Gross | % Change | Theaters | Per Theater | Total Gross | Week |
|---|---|---|---|---|---|---|---|
| Sep 29, 2017 | 5 | $8,529,602 | 2,552 | $3,342 | $8,529,602 | 1 | |
| Oct 6, 2017 | 9 | $5,598,369 | -34% | 2,552 | $2,194 | $14,127,971 | 2 |
| Oct 13, 2017 | 12 | $2,067,080 | -63% | 1,983 | $1,042 | $16,195,051 | 3 |
| Oct 20, 2017 | 21 | $390,748 | -81% | 535 | $730 | $16,585,799 | 4 |
| Oct 27, 2017 | 32 | $178,909 | -54% | 263 | $680 | $16,764,708 | 5 |
| Nov 3, 2017 | 44 | $68,117 | -62% | 104 | $655 | $16,832,825 | 6 |
| Nov 10, 2017 | 50 | $33,578 | -51% | 67 | $501 | $16,866,403 | 7 |
Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services. For more information, please contact us at research@the-numbers.com.